These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27588951)

  • 1. Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity.
    Mair B; Konopka T; Kerzendorfer C; Sleiman K; Salic S; Serra V; Muellner MK; Theodorou V; Nijman SM
    PLoS Genet; 2016 Sep; 12(9):e1006279. PubMed ID: 27588951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network.
    Takaku M; Grimm SA; Roberts JD; Chrysovergis K; Bennett BD; Myers P; Perera L; Tucker CJ; Perou CM; Wade PA
    Nat Commun; 2018 Mar; 9(1):1059. PubMed ID: 29535312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases.
    Karthik IP; Desai P; Sukumar S; Dimitrijevic A; Rajalingam K; Mahalingam S
    J Biol Chem; 2018 Apr; 293(15):5624-5635. PubMed ID: 29467226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness.
    Gaynor KU; Grigorieva IV; Allen MD; Esapa CT; Head RA; Gopinath P; Christie PT; Nesbit MA; Jones JL; Thakker RV
    Horm Cancer; 2013 Jun; 4(3):123-39. PubMed ID: 23435732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.
    Zhang X; Peng D; Xi Y; Yuan C; Sagum CA; Klein BJ; Tanaka K; Wen H; Kutateladze TG; Li W; Bedford MT; Shi X
    Nat Commun; 2016 Mar; 7():10810. PubMed ID: 26960573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
    Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S
    Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer.
    Sereesongsaeng N; McDowell SH; Burrows JF; Scott CJ; Burden RE
    Breast Cancer Res; 2020 Dec; 22(1):139. PubMed ID: 33298139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.
    Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X
    Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EHMT2 is a metastasis regulator in breast cancer.
    Kim K; Son MY; Jung CR; Kim DS; Cho HS
    Biochem Biophys Res Commun; 2018 Feb; 496(2):758-762. PubMed ID: 29337058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RNA-binding protein HuR regulates GATA3 mRNA stability in human breast cancer cell lines.
    Licata LA; Hostetter CL; Crismale J; Sheth A; Keen JC
    Breast Cancer Res Treat; 2010 Jul; 122(1):55-63. PubMed ID: 19728080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.
    Casciello F; Al-Ejeh F; Kelly G; Brennan DJ; Ngiow SF; Young A; Stoll T; Windloch K; Hill MM; Smyth MJ; Gannon F; Lee JS
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7077-7082. PubMed ID: 28630300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA3 somatic mutations are associated with clinicopathological features and expression profile in TCGA breast cancer patients.
    Afzaljavan F; Sadr AS; Savas S; Pasdar A
    Sci Rep; 2021 Jan; 11(1):1679. PubMed ID: 33462316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
    Bianco G; Coto-Llerena M; Gallon J; Kancherla V; Taha-Mehlitz S; Marinucci M; Konantz M; Srivatsa S; Montazeri H; Panebianco F; Tirunagaru VG; De Menna M; Paradiso V; Ercan C; Dahmani A; Montaudon E; Beerenwinkel N; Kruithof-de Julio M; Terracciano LM; Lengerke C; Jeselsohn RM; Doebele RC; Bidard FC; Marangoni E; Ng CKY; Piscuoglio S
    Commun Biol; 2022 Apr; 5(1):373. PubMed ID: 35440675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
    Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
    Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
    Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
    Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
    Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
    Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.
    Takaku M; Grimm SA; De Kumar B; Bennett BD; Wade PA
    Nucleic Acids Res; 2020 May; 48(9):4756-4768. PubMed ID: 32232341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distinct mechanism for coactivator versus corepressor function by histone methyltransferase G9a in transcriptional regulation.
    Purcell DJ; Jeong KW; Bittencourt D; Gerke DS; Stallcup MR
    J Biol Chem; 2011 Dec; 286(49):41963-41971. PubMed ID: 21984853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer.
    Yu W; Huang W; Yang Y; Qiu R; Zeng Y; Hou Y; Sun G; Shi H; Leng S; Feng D; Chen Y; Wang S; Teng X; Yu H; Wang Y
    Cell Death Dis; 2019 Nov; 10(11):832. PubMed ID: 31685800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.